Shanxi Changcheng Microlight Equipment Co Ltd's EV / EBITDA of -12.9x ranks in the 20.8% percentile for the Sector. The following table provides additional summary stats: ...
Homologous recombination deficiency signature (HRDsig+) and the genomic landscape of clinically advanced prostate carcinoma (CAPC). This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback